Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hematologic Diseases × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 58 Lymphoid 43 Myeloid 34 Plasma cell 26 Classical hematology 8 Sarcoma 2 Genitourinary 2 CNS 2 Thoracic 1 Other neoplasm 1 Other 1 Breast 1

Conditions

Obesity 192 Neoplasms 73 Breast Neoplasms 61 Mucositis 59 Sexual Dysfunction, Physiological 55 Overweight 50 Polycystic Ovary Syndrome 48 Dyspnea 29 Motor Activity 27 Constipation 27 Head and Neck Neoplasms 26 Prostatic Neoplasms 23 Weight Loss 22 Multiple Endocrine Neoplasia Type 1 17 Colorectal Neoplasms 17 Stomatitis 15 Pain 14 Opioid-Induced Constipation 14 Lung Neoplasms 14 Depression 13 Diabetes Mellitus 12 Insulin Resistance 11 Endometrial Neoplasms 11 Cardiovascular Diseases 11 Sexuality 10 Sexual Dysfunctions, Psychological 10 Fatigue 9 Diabetes Mellitus, Type 2 9 Stomach Neoplasms 8 Sedentary Behavior 8

Interventions

Surveys and Questionnaires 1 Sugars 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡